Obstetric Cholestasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Condition: Intrahepatic Cholestasis Associated With Alcoholic Liver DiseaseInterventions: Drug: Ademetionine IV+tablet; Drug: Ademetionine tabletSponsors: Abbott; Ascent; Datamap; ClinIntel; CatalentActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2014 Category: Research Source Type: clinical trials
Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Condition: Intrahepatic Cholestasis Associated With Alcoholic Liver DiseaseInterventions: Drug: Ademetionine IV+tablet; Drug: Ademetionine tabletSponsors: Abbott; Ascent; Datamap; ClinIntel; CatalentRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 21, 2014 Category: Research Source Type: clinical trials
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention: Drug: LUM001Sponsor: Lumena Pharmaceuticals, Inc.Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention: Drug: LUM001Sponsor: ShireRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention: Drug: LUM001Sponsor: Lumena Pharmaceuticals, Inc.Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials